Invitro Release Study of Sodium Salicylate from Lecithin Based Phospholipid Microemulsions
Authors
Abstract:
Sodium salicylate containing microemulsions have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant and oil. The effects of formulation variables on the release profile of the drug from microemulsion through intact rat skin were also determined experimentally. In this investigation, two commercially available lecithins (namely Epikuron 200 and Epikuron 170), three short chain alcohols (n-butanol, isopropanol and n-propanol) and isopropyl myristate (IPM) were used as surfactant, cosurfactant and oil, respectively. The water phase was composed of sodium salicylate solution (2% w/v). To investigate the release profile, samples with 25% wt% total surfactant content were prepared with different surfactant/cosurfactant weight ratios (Km of 1:1 and 1.5:1) and various amounts of drug solution (from 7 to 35 wt%), depending on the nature of alcohol. Two compartment Franz diffusion cells, equipped with rat skin as the absorption membrane, were employed for release studies. All experiments were performed at room temperature and sampling was taken over 12 hours with one-hour intervals. The amount of drug released was determined spectrophotometrically and the permeation parameters were then calculated. Results showed that systems formulated with 7 and 9% drug solution, were not capable of releasing the drug with a lower rate, compared to the corresponding drug solutions, while in other systems, a lower release rate was observed in comparison to the control samples. In general, among the systems investigated, those prepared with n-propanol at Km of 1.5:1 and 11-20 wt% and 29% dispersed phase showed a relatively lower absorption rate, comparing to the corresponding control samples , regardless of the nature of surfactant and cosurfactant. Under passive conditions, the flux from microemulsions followed the zero order behavior with respect to the donor concentration.
similar resources
invitro release study of sodium salicylate from lecithin based phospholipid microemulsions
sodium salicylate containing microemulsions have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant and oil. the effects of formulation variables on the release profile of the drug from microemulsion through intact rat skin were also determined experimentally. in this investigation, two commercially available lecithins (namely epikuron 2...
full textLecithin - Stabilized Microemulsion - Based Organogels for Topical Application of Ketorolac Tromethamine. II. Invitro Release Study
Ketorolac tromethamine (KT) containing microemulsion-based gels (MBGs) have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant (soybean lecithin; Epikuron 200) and oil (isopropyl myristate; IPM) and the effect of formulation variables on the release profile of the drug from MBGs through intact guinea pig skin and various artificial membr...
full textLecithin - Stabilized Microemulsion - Based Organogels for Topical Application of Ketorolac Tromethamine. II. Invitro Release Study
Ketorolac tromethamine (KT) containing microemulsion-based gels (MBGs) have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant (soybean lecithin; Epikuron 200) and oil (isopropyl myristate; IPM) and the effect of formulation variables on the release profile of the drug from MBGs through intact guinea pig skin and various artificial membr...
full textlecithin - stabilized microemulsion - based organogels for topical application of ketorolac tromethamine. ii. invitro release study
ketorolac tromethamine (kt) containing microemulsion-based gels (mbgs) have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant (soybean lecithin; epikuron 200) and oil (isopropyl myristate; ipm) and the effect of formulation variables on the release profile of the drug from mbgs through intact guinea pig skin and various artificial membr...
full textComparative Invitro Release of Diclofenac Sodium Gel from Different Marketed Products
Diclofenac Sodium, a non steroidal anti-inflammatory agent is frequently prescribed for the long term treatment of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. The drug undergoes substantial first pass effect and only 50% of drug is available systemically. Further, the drug is known to induce ulceration and bleeding of the intestinal wall. To avoid the adverse effect, altern...
full textMy Resources
Journal title
volume Volume 2 issue Number 2
pages 95- 101
publication date 2010-11-20
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023